Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06433726
Status:
RECRUITING
Last Update Posted:
2024-05-30
First Post:
2024-05-13
Brief Title:
A Phase l Study of By101921 an Oral PARP7 Inhibitor in Patients With Advanced Solid Tumors
Sponsor:
Chengdu Baiyu Pharmaceutical Co Ltd
Organization:
Chengdu Baiyu Pharmaceutical Co Ltd
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Solid Tumor Adult |
Keywords: